Statement: Broader Medicare Coverage of Leqembi Available Following FDA Traditional Approval
(Source – www.cms.gov/newsroom) Broader Medicare coverage is now available for Biogen and Eisai’s Leqembi (the brand name for lecanemab) following
Read More
Alzheimer’s/Dementia
Why the Next Big Hope for Alzheimer’s Might Not Help Most Black Patients
(By Arthur Allen for KFF Health News) This week the FDA is expected to approve what many scientists and doctors
Read MoreAfter ICU discharge, Alzheimer’s patients’ risk of dying doubles: Study
(By Bari Faye Dean for Becker’s Hospital Review) Older adults with Alzheimer’s disease and related dementia are twice as likely
Read MoreAn Alzheimer’s drug is on the way, but getting it may still be tough. Here’s why
(By Jon Hamilton for NPR) The first drug shown to slow down Alzheimer’s disease is likely to receive full approval
Read MoreDementia Can Take a Toll on Financial Health, as Some Families Learn the Hard Way
By Sara Boden, WESA on June 20, 2023 for Kaiser Family Foundation Angela Reynolds knew her mother’s memory was slipping,
Read MoreHuntington’s spreads like ‘fire in the brain.’ Scientists say they’ve found the spark
By Jon Hamilton on June 19, 2023 for NPR Diseases like Alzheimer’s, Parkinson’s, and Huntington’s are caused by toxic clumps
Read MoreA loved one’s dementia will break your heart. Don’t let it wreck your finances
(By Sarah Boden for NPR) Sharon Gwinn had been married almost 30 years when she cleared out the savings and
Read MoreBy boosting memory consolidation, scientists may be able to help Alzheimer’s patients
(By Jon Hamilton for NPR) During sleep, the brain strengthens memories it expects to use in the future. Now, scientists
Read MoreElectrical pulses that synchronize the sleeping brain appear to boost memory
By Jon Hamilton for NPR on June 2, 2023 A little brain stimulation at night appears to help people remember
Read MoreHow Medicare’s Aduhelm decision revived old questions about new drugs
(By Kerry Dooley Young for STAT) Medicare’s decision to withhold coverage for Biogen’s Aduhelm despite the Food and Drug Administration’s
Read More